- Home
- VWAV vs INO Comparison
VWAV vs INO Comparison
Compare VWAV & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VWAV
- INO
- Stock Information
- Founded
- VWAV 2024
- INO 1979
- Country
- VWAV United States
- INO United States
- Employees
- VWAV N/A
- INO N/A
- Industry
- VWAV Computer Software: Prepackaged Software
- INO Medical/Dental Instruments
- Sector
- VWAV Technology
- INO Health Care
- Exchange
- VWAV Nasdaq
- INO Nasdaq
- Market Cap
- VWAV 162.2M
- INO 136.6M
- IPO Year
- VWAV N/A
- INO 1998
- Fundamental
- Price
- VWAV $13.39
- INO $2.58
- Analyst Decision
- VWAV
- INO Buy
- Analyst Count
- VWAV 0
- INO 5
- Target Price
- VWAV N/A
- INO $8.80
- AVG Volume (30 Days)
- VWAV 342.9K
- INO 1.0M
- Earning Date
- VWAV 11-26-2025
- INO 11-10-2025
- Dividend Yield
- VWAV N/A
- INO N/A
- EPS Growth
- VWAV N/A
- INO N/A
- EPS
- VWAV N/A
- INO N/A
- Revenue
- VWAV N/A
- INO $182,337.00
- Revenue This Year
- VWAV N/A
- INO N/A
- Revenue Next Year
- VWAV N/A
- INO $14,751.49
- P/E Ratio
- VWAV N/A
- INO N/A
- Revenue Growth
- VWAV N/A
- INO N/A
- 52 Week Low
- VWAV $2.06
- INO $1.30
- 52 Week High
- VWAV $14.05
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- VWAV N/A
- INO 58.30
- Support Level
- VWAV N/A
- INO $2.21
- Resistance Level
- VWAV N/A
- INO $2.49
- Average True Range (ATR)
- VWAV 0.00
- INO 0.14
- MACD
- VWAV 0.00
- INO -0.01
- Stochastic Oscillator
- VWAV 0.00
- INO 81.29
About VWAV VisionWave Holdings Inc. Common Stock
VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.